Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 14;11(1):23-27.
doi: 10.4103/GMIT.GMIT_141_20. eCollection 2022 Jan-Mar.

Treating Vaginal Relaxation Syndrome Using Erbium: Yttrium Aluminum Garnet Fractional Laser: A Retrospective Study

Trisniartami Setyaningrum  1   2 , Brahmana Askandar Tjokroprawiro  3 , M Yulianto Listiawan  2 , Budi Santoso  3 , Cita Rosita Sigit Prakoeswa  2
Affiliations

Treating Vaginal Relaxation Syndrome Using Erbium: Yttrium Aluminum Garnet Fractional Laser: A Retrospective Study

Trisniartami Setyaningrum et al. Gynecol Minim Invasive Ther. .

Abstract

Objectives: Vaginal relaxation syndrome (VRS) comprises vaginal laxity and stress urinary incontinence (SUI). Laser vaginal tightening (LVT) therapy using a fractional erbium:yttrium aluminum garnet (Er:YAG) 2.940 nm laser may represent a nonsurgical option for both complaints. This study evaluates the effectiveness and side effects of fractional Er:YAG laser therapy in VRS patients. The improvement in VRS was evaluated.

Materials and methods: This is a retrospective study analyzing the medical records of patients treated with fractional Er:YAG laser therapy in our private clinic in Surabaya, Indonesia. Objective questions were asked to rate patients' satisfaction with the results of the therapy, namely dissatisfaction, and mild, moderate, or strong satisfaction. Statistical analysis used, data were input into tables in Microsoft Excel.

Results: Twenty-four VRS patients (54% with vaginal laxity, 33% with SUI, and 13% with vaginal laxity and SUI) were studied. Most of the patients were 36-45-year-old and had 2 children, and 79% of the patients had had a vaginal delivery. After 3 LVTs, mild satisfaction was observed in 15% of patients, moderate satisfaction was noted in 54% of patients, and high satisfaction was noted in 31% of patients. Among 11 patients with SUI, 36% recovered after the first LVT, and 100% recovered after the second LVT therapy. One patient experienced mild fluor albus as a side effect.

Conclusion: LVT therapy with a fractional Er:YAG laser was determined to be effective and safe as a treatment for VRS.

Keywords: Erbium:yttrium aluminum garnet fractional laser; stress urinary incontinence; vaginal laxity; vaginal relaxation syndrome.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Probe of fractional erbium: yttrium aluminium garnet laser for vagina
Figure 2
Figure 2
Probe of fractional erbium: yttrium aluminium garnet for vaginal introitus
See this image and copyright information in PMC

References

    1. Gaviria JE. Vaginal Tightening (LVT) – Evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome. J LAHA. 2012;2012:59–66.
    1. Manzini C, Friedman T, Turel F, Dietz HP. Vaginal laxity: What measure of levator ani distensibility is the most predictive? Ultrasound Obstet Gynecol. 2019;55:683–7. - PMC - PubMed
    1. Addis IB, Van Den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH, et al. Sexual activity and function in middle-aged and older women. Obstet Gynecol. 2006;107:755–64. - PMC - PubMed
    1. Campbell P, Krychman M, Gray T, Vickers H, Money-Taylor J, Li W, et al. Self-reported vaginal laxity-prevalence, impact, and associated symptoms in women attending a urogynecology clinic. J Sex Med. 2018;15:1515–7. - PubMed
    1. Pauls RN, Fellner AN, Davila GW. Vaginal laxity: A poorly understood quality of life problem; a survey of physician members of the International Urogynecological Association (IUGA) Int Urogynecol J. 2012;23:1435–48. - PubMed